TERBINAFINE-WT terbinafine (as hydrochloride) 250 mg tablet blister pack

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Toimeaine:

terbinafine hydrochloride, Quantity: 281.28 mg

Saadav alates:

Medis Pharma Pty Ltd

INN (Rahvusvaheline Nimetus):

terbinafine hydrochloride

Ravimvorm:

Tablet, uncoated

Koostis:

Excipient Ingredients: microcrystalline cellulose; colloidal anhydrous silica; sodium starch glycollate type A; magnesium stearate; hypromellose

Manustamisviis:

Oral

Ühikuid pakis:

42

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

? Treatment in adults of ringworm (tinea corporis, tinea cruris and tinea pedis) due to infection caused by dermatophytes such as Trichophyton (e.g. T. rubrum, T. mentagrophytes, T. verrucosum, T. violaceum), Microsporum canis and Epidermophyton floccosum, where oral therapy is considered appropriate owing to the site, severity or extent of the infection, and the infection is not responsive to topical therapy. ? Onychomycosis in adults (fungal infection of the nail) caused by dermatophyte fungi.

Toote kokkuvõte:

Visual Identification: White to off-white, uncoated biconvex, bevelled edge tablet, engraved 'TER' and '250' with a break line on one side and plain on the other; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2014-03-20